Do glyprolines have activity of their own?

Pro-Gly-Pro and related glyprolines have been studied for activity in their own right, separately from their use as stabilising extensions. The two roles should not be conflated.

Why not just use more prolines?

Consecutive prolines form a rigid polyproline helix with quite different properties. The glycine between them provides flexibility that a proline run would not.

Which peptides use this motif?

Semax appends it to an ACTH fragment and Selank to a tuftsin fragment. Both were developed at the same Russian institute.

Semax (ACTH Fragment Peptide)

What Are Glyprolines? The Pro-Gly-Pro Motif Explained

JMWritten & reviewed by Jack Muncaster · Founder, UK PeptidesLast reviewed 2026-08-233 cited sources

Glyprolines are short proline- and glycine-containing peptides, of which Pro-Gly-Pro is the best known. The motif derives from collagen, resists enzymatic degradation because proline constrains the backbone conformation peptidases require, and is appended to designed peptides such as Semax and Selank to extend their stability.

Key facts

Motif: Pro-Gly-Pro (PGP)
Class: Glyprolines
Biological origin: Collagen degradation products
Key property: Peptidase resistance
Used in: Semax, Selank
Structural basis: Proline ring restricts backbone rotation

Where the motif comes from

Collagen is unusually rich in proline and glycine — its characteristic triple helix depends on a repeating Gly-X-Y pattern where X and Y are frequently proline or hydroxyproline. Short proline-glycine fragments are therefore natural products of collagen turnover, and Pro-Gly-Pro appears in that context. Glyprolines as a class are these short proline-glycine peptides.

Why proline is the stability residue

Proline is structurally unique among the twenty proteinogenic amino acids: its side chain loops back and bonds to its own backbone nitrogen, forming a five-membered ring. Two consequences follow. The backbone amide has no hydrogen to donate, and rotation about the N-Cα bond is locked. Proteolytic enzymes generally require an extended, rotatable backbone to bind their substrate, so bonds near proline are poor substrates for most of them.

Research material referenced

Semax 10mg — third-party HPLC tested

View — £24.99

Why glycine sits between the two prolines

Glycine has no side chain at all, which makes it the most conformationally flexible residue available. Placing it between two rigid prolines gives the tripeptide a hinge — rigid, flexible, rigid. That combination is more useful than three consecutive prolines, which would produce a stiff polyproline segment with quite different properties.

How this is used in peptide design

Appending Pro-Gly-Pro to a bioactive fragment is a stabilisation strategy: keep the sequence responsible for the activity, add a motif that resists degradation. Semax uses it on an ACTH fragment; Selank uses it on a tuftsin fragment. In both cases the design intent is the same, and in Semax's case the extension does double duty by also displacing the residues responsible for the parent hormone's adrenal activity.

The trade-off

Adding residues to a short bioactive peptide risks interfering with the binding that produces its activity. That the approach works in these cases indicates the active determinants sit in the retained N-terminal fragment rather than being distributed across the whole molecule. It is not a universal technique — it works where the pharmacophore is localised.

Extended research context

The Semax (ACTH Fragment Peptide) deep dive

Deep dive: what the Pro-Gly-Pro extension actually accomplishes

Semax is built from a four-residue fragment of ACTH with Pro-Gly-Pro appended, and that appendix does two separate jobs at once. Proline is the only proteinogenic amino acid whose side chain bonds back to its own backbone nitrogen, forming a ring that removes the amide hydrogen and locks rotation. Proteolytic enzymes generally need an extended, rotatable backbone at their active site, so bonds near proline are poor substrates for most of them — which is why proline-rich motifs recur throughout stabilised peptide design. The second job is subtractive: Pro-Gly-Pro occupies the positions where ACTH carries Arg-Trp-Gly, and those are the residues contributing to the parent hormone's adrenal-stimulating activity. One substitution therefore buys protease resistance and removes an unwanted pharmacology, which is unusually economical design.

Deep dive: the naming point worth getting right

Semax is near-universally described as an ACTH(4-10) analogue, and peer-reviewed paper titles use that phrase. Structurally it is not quite that. ACTH residues 4 to 10 are Met-Glu-His-Phe-Arg-Trp-Gly; Semax is Met-Glu-His-Phe-Pro-Gly-Pro. The first four residues match and the last three are wholly different — replacement rather than modification. PubChem, indexing by structure rather than design lineage, records it as ACTH(4-7) plus Pro-Gly-Pro. Neither name is wrong, but the loose one obscures the fact that the substituted segment is precisely the functionally consequential part.

Deep dive: reading an unevenly distributed evidence base

Semax's roughly 231 indexed records split along an unusual line. Mechanistic work — BDNF and trkB expression in rat hippocampus, transcriptomics in focal cerebral ischaemia, neurotrophin dynamics across brain regions — appears in international journals in English and can be assessed directly. Clinical work is concentrated in Russian-language publications, principally the Korsakov Journal of Neurology and Psychiatry, indexed by translated title and often without accessible English full text, much of it predating current standards for pre-registration and reporting. The honest position is that this is evidence which is difficult to verify independently, which is a different thing from evidence that is absent, and a different thing again from evidence that is established.

Research applications

▸Neurotrophin expression research (BDNF, NGF, TrkB, TrkA)
▸Neuroprotection and cerebral ischaemia models
▸Study of proline-stabilised peptide design
▸Comparative work on ACTH fragments without steroidogenic activity
▸Transcriptomic profiling in rodent brain models

Handling checklist

✓Store lyophilised material cold, dry and protected from light
✓Expect methionine oxidation as the degradation route (+16 Da; only one Met, so not +32)
✓No reducing agent needed — the sequence contains no cysteine
✓Introduce diluent gently against the vial wall; swirl rather than shake
✓Aliquot to avoid repeated freeze-thaw cycles
✓Check whether a certificate reports net peptide content or gross salt weight

Common research-handling mistakes

Learnt from thousands of researcher orders across our UK labs.

✗ Describing Semax as ACTH(4-10) without qualification

Fix: It shares only residues 4-7; Pro-Gly-Pro replaces Arg-Trp-Gly, and that replacement is the design's whole point.

✗ Treating Russian registration as equivalent to MHRA approval

Fix: Authorisations are jurisdictional and do not transfer. Semax has never been assessed by the MHRA, EMA or FDA.

✗ Reading a BDNF expression change as a demonstrated outcome

Fix: The studies measured gene and protein expression in rats. Expression is upstream of function and upstream again of any clinical claim.

✗ Assuming a named receptor exists

Fix: No primary receptor has been definitively established; the literature characterises downstream effects more confidently than the initiating event.

✗ Expecting ACTH-like adrenal effects

Fix: Semax does not stimulate adrenal steroidogenesis — the responsible residues were substituted out.

Continue researching

Peer-reviewed guides, comparators and matched reference materials.

Frequently asked questions

Do glyprolines have activity of their own?: Pro-Gly-Pro and related glyprolines have been studied for activity in their own right, separately from their use as stabilising extensions. The two roles should not be conflated.
Why not just use more prolines?: Consecutive prolines form a rigid polyproline helix with quite different properties. The glycine between them provides flexibility that a proline run would not.
Which peptides use this motif?: Semax appends it to an ACTH fragment and Selank to a tuftsin fragment. Both were developed at the same Russian institute.

Primary sources & clinical trials

Peer-reviewed research and registered trials from PubMed, ClinicalTrials.gov, PubChem, FDA and NIH. All links open in a new tab and point to the primary source, so every claim can be verified at origin.

Written and reviewed by

Jack Muncaster · Founder, UK Peptides

Jack founded UK Peptides in Manchester after repeatedly receiving research compounds with missing or recycled paperwork. He is responsible for supplier selection, batch release decisions and the content published in this research library. Every article here is sourced to primary literature and every product page to a signed third-party certificate.

How we write and check this content Report a factual error in this article

More Semax (ACTH Fragment Peptide) articles

Popular across the research hub

One flagship guide from every other research category — keep exploring.

← Back to Forum